CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Sarcos goes public following 2020 breakthroughs

By Andrew Knoll

22:11, 16 September 2021

Sarcos Robotics
Sarcos Robotics exoskeleton - Photo: Sarcos Robotics

Sarcos Robotics is set to go public with shares trading on Nasdaq beginning 27 September, following a business combination with SPAC Rotor Acquisition Corp, a move that has been planned since April.

The company hopes for a valuation of $1.3bn (£942.5m).

An analysis of its prospectus and financial might produce a torrent of technical jargon and financial nomenclature. But a glance at one of Sarcos's prominent inventions provokes a more colloquial observation: it looks like Iron Man's suit.

While they’ve designed pirates for Disney and majestic fountains for Las Vegas’s Bellagio Hotel, their superhero chic Guardian XO full body powered exoskeleton has attracted considerable attention, including mention by Time Magazine as one of 2020’s best 100 inventions.

A history of innovation

Spun off a University of Utah lab in the ‘80s, the Salt Lake City-based Sarcos has churned out advancements in robotics and microelectromechanical systems, with strong emphasis on military and industrial applications. Defense, public safety, transportation, logistics, mining, extraction, health care and manufacturing are among the areas Sarcos has developed across five different decades.

Sarcos has also enmeshed elements of both the past and present with its Guardian exoskeleton. It may appear futuristic, but many in the robotics industry have been trending toward lighter, more compact devices in recent years. That did not deter the years-long development process, which seeks to simplify the physics of robot-aided lifting and handling while simultaneously filling in interstitial space.


17,943.90 Price
+1.660% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8


51,702.10 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00


2,024.07 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.30


0.55 Price
-0.870% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

There existed a relatively broad gap between what could safely be lifted by one or two people and what required pallets and heavy machinery. The exoskeleton effectively filled that gap by capably handling loads between 80 and 200 pounds (36 to 91 kilograms). The Guardian XT, based on the XO’s upper-body structure, and Guardian GT, a mounted robot with up to 1,000 pounds (454 kilograms) of lifting capacity, and all have a wide array of applications in industry, defense, public safety and beyond.

Looking ahead

While much of the public discourse surrounding robotics have centred on automation and robots supplanting organic labor, Sarcos’s efforts have veered toward cooperation rather than competition between man and machine.

Their efforts with the aforementioned models all typify how robots and humans can work in conjunction, whether they are physically joined, as in the case of the exoskeleton, or controlled remotely through teleoperation as is the case for the Guardian GT, which can move heavy components in conditions not apt for humans.

“The growing shortage of skilled workers that are able to conduct physically demanding tasks is a critical problem for companies, industries, and the global economy,” said Sarcos CEO Ben Wolff in a statement.

“Sarcos has a unique opportunity to usher in a new age of human and machine collaboration by deploying a fleet of its highly dexterous mobile robotic systems that augment humans rather than replace them.”

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading